ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Annual Conference
May 31–June 3, 2026
Denver, CO|Sheraton Denver
Latest Magazine Issues
Mar 2026
Jul 2025
Latest Journal Issues
Nuclear Science and Engineering
March 2026
Nuclear Technology
February 2026
Fusion Science and Technology
April 2026
Latest News
NRC approves TerraPower construction permit
Today, the Nuclear Regulatory Commission announced that it has approved TerraPower’s construction permit application for Kemmerer Unit 1, the company’s first deployment of Natrium, its flagship sodium fast reactor.
This approval is a significant milestone on three fronts. For TerraPower, it represents another step forward in demonstrating its technology. For the Department of Energy, it reflects progress (despite delays) for the Advanced Reactor Demonstration Program (ARDP). For the NRC, it is the first approval granted to a commercial reactor in nearly a decade—and the first approval of a commercial non–light water reactor in more than 40 years.
Oyeon Kum, Seung Uk Heo, Sang Hyoun Choi, Yongkeun Song, Sung-Ho Cho
Nuclear Technology | Volume 192 | Number 3 | December 2015 | Pages 208-214
Technical Paper | Accelerators | doi.org/10.13182/NT14-121
Articles are hosted by Taylor and Francis Online.
Because of the encouraging results obtained at worldwide heavy-ion therapy facilities, the first hospital-based heavy-ion accelerator therapy facility is under construction in Busan, Korea, at the Korea Institute of Radiological and Medical Sciences. The compact accelerator will deliver beams of heavy ions, specifically carbon ions of energy 430 MeV/u. This study focuses on radiation protection aspects concerning materials activation and facility shielding. Radiation shielding was evaluated with two different Monte Carlo codes (MCNPX and FLUKA), and materials activation studies were performed using FLUKA and a combination of MCNPX+CINDER’90 codes.